VC  Emergent Technologies

http://www.emergenttechnologies.com





     Office Locations:

11412 Bee Caves Rd., Suite 300
Austin, TX 78738
Phone: 512-263-3232
Fax: 512-263-3236

 

Stages:

  • Early
  • Seed


 

Industries:

  • Consumer Products & Services
  • Life Sciences & Healthcare

  •  

    Description:

    ETI is a venture capital firm that specializes in forming, funding, commercializing, and managing companies for the purpose of converting institutional and university-based technology into high return ventures. Emergent becomes a full time business partner and acts as an active management team with a portfolio company. Once the technology is proven and markets are demonstrated, ultimate value may be achieved through a sublicense, IPO or sale of the technology.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Blair Duncan Executive Vice President & CFO
    Ed Merrifield Vice President & COO
    Edward K. Clark Executive Vice President
    Kris Looney President
    Thomas A. Harlan Chairman & CEO

     

    Portfolio companies include:


      AeonClad Biomedical
        web link


      Appian Labs
        web link


      Auxano Biomedical
        web link


      Beacon Sciences
        web link


      Caisson Biotech
        web link


      Choncept
        web link


      Enavail
        web link


      Heparinex
        web link


      Hyalose
        web link


      Pure Protein
        web link


      Pure Transplant Solutions
        web link


      Receptor Logic
        web link


      Reveal Sciences
        web link


      Selenium Bio
        web link


     

    Recent News: